Crossmark

In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-019-1852-8

Published Online: 2019-03-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Benabdoun, Houda Abir

Kulbay, Merve

Rondon, Elsa-Patricia

Vallières, Francis

Shi, Qin

Fernandes, Julio

Fahmi, Hassan

Benderdour, Mohamed https://orcid.org/0000-0002-7853-2133
Funding

Funding for this research was provided by:

Institute of Musculoskeletal Health and Arthritis (MOP-130293)

Fonds de Recherche en Orthopédie-HSCM
License Information

Text and Data Mining valid from 2019-03-12
More Information

Article History

Received: 6 November 2018

Accepted: 20 February 2019

First Online: 12 March 2019

Ethics approval and consent to participate

: The local ethics committee of “Hôpital du Sacré-Coeur de Montréal” and The Research Centre of the “Hôpital du Sacré-Coeur de Montréal” approved the study in human and in animal, respectively. Informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.